AI assistant
Sending…
Medtronic plc — Director's Dealing 2017
Jul 11, 2017
29841_dirs_2017-07-11_94101972-e9c8-45cc-8009-e53363b96be2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2017-07-10
Reporting Person: Lenehan James T (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-07-10 | Ordinary Shares | M | 1010 | $52.84 | Acquired | 46353 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-07-10 | Stock Option (Right to Buy) | $52.84 | M | 1010 | Disposed | 2017-09-01 | Ordinary Shares (1010) | Direct |
Footnotes
F1: This option to purchase 1,010 New Medtronic ordinary shares for $52.84 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,010 Medtronic common stock shares for $52.84 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
More from Medtronic plc
Report Publication Announcement
2026
Jun 3
Regulatory Filings
2026
May 28
Board/Management Information
2026
May 18
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 26
Director's Dealing
2026
Feb 24
Interim / Quarterly Report
2026
Feb 24
Earnings Release
2026
Feb 17
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Jan 29